2,6-Lutidine → HCID 70945613, 화합물

HRID 1261504

반응식

HRID 1261504 반응식
[CH:1]1([CH2:6][C@H:7]([N:11]2[CH2:19][C:18]3[C:13](=[CH:14][CH:15]=[CH:16][C:17]=3[C:20]([F:23])([F:22])[F:21])[C:12]2=[O:24])[C:8](O)=[O:9])[CH2:5][CH2:4][CH2:3][CH2:2]1.C(Cl)(=O)C(Cl)=O.[CH3:31][C:32]1([CH3:44])[O:36][C@@H:35]([C:37]2[N:38]=[CH:39][C:40]([NH2:43])=[N:41][CH:42]=2)[CH2:34][O:33]1.N1C(C)=CC=CC=1C>C(Cl)Cl.CN(C)C=O>[CH:1]1([CH2:6][C@H:7]([N:11]2[CH2:19][C:18]3[C:13](=[CH:14][CH:15]=[CH:16][C:17]=3[C:20]([F:21])([F:22])[F:23])[C:12]2=[O:24])[C:8]([NH:43][C:40]2[CH:39]=[N:38][C:37]([C@H:35]3[CH2:34][O:33][C:32]([CH3:44])([CH3:31])[O:36]3)=[CH:42][N:41]=2)=[O:9])[CH2:2][CH2:3][CH2:4][CH2:5]1

참가 물질

7

반응 조건

온도
0 °C

실험 절차

A solution of (S)-3-cyclopentyl-2-(1-oxo-4-trifluoromethyl-1,3-dihydro-isoindol-2-yl)-propionic acid (prepared as in Example 1, 125 mg, 0.37 mmol) in methylene chloride (10 mL) was treated with N,N-dimethylformamide (1 drop) and cooled to 0° C. It was then treated with a solution of oxalyl chloride (2.0 M in methylene chloride, 220 μL, 0.44 mmol) and stirred for 10 min at 0° C. and then warmed to room temperature and stirred for 30 min. After this time, the reaction mixture was concentrated in vacuo to about 1 mL and then it was added to a flask containing 5-((S)-2,2-dimethyl-[1,3]dioxolan-4-yl)-pyrazin-2-ylamine (prepared as in WO2004052869, Example 54, 107 mg, 0.55 mmol) and 2,6-lutidine (81 μL, 0.73 mmol) in methylene chloride (10 mL) at 0° C. The reaction mixture was then allowed to warm up to room temperature and stirred overnight for 16 h. After this time, the reaction mixture was quenched with an aqueous saturated sodium bicarbonate solution (10 mL) and extracted with methylene chloride (3×10 mL). The organic layers were then combined and washed with a 1N aqueous hydrochloric acid solution (10 mL), dried over magnesium sulfate, filtered to remove the drying agent and the filtrate concentrated in vacuo. The crude material was purified using an Analogix Intelliflash 280 chromatography system (12 g silica gel column, 15-40% ethyl acetate/hexanes) to afford (S)-3-cyclopentyl-N-[5-((S)-2,2-dimethyl-[1,3]dioxolan-4-yl)-pyrazin-2-yl]-2-(1-oxo-4-trifluoromethyl-1,3-dihydro-isoindol-2-yl)-propionamide (78 mg, 41%) as a white foam: [α]27D=−18.0° (c=0.15, methylene chloride); HR-ES(+) m/e calcd for C26H29N4O4F3 [M+Na]+ 541.2033, observed 541.2030; 1H NMR (300 MHz, DMSO-d6) δ 11.37 (s, 1H), 9.21 (d, J=1.21 Hz, 1H), 8.48 (d, J=1.21 Hz, 1H), 8.02 (t, J=8.00 Hz, 2H), 7.72-7.82 (m, 1H), 5.12-5.29 (m, 2H), 5.05 (d, J=17.81 Hz, 1H), 4.76 (d, J=18.11 Hz, 1H), 4.35 (dd, J=6.64, 8.45 Hz, 1H), 3.93 (dd, J=6.64, 8.45 Hz, 1H), 1.04-2.20 (m, 17H).

후처리

  1. temperaturewarmed to room temperature
  2. stirringstirred for 30 min
  3. concentrationAfter this time, the reaction mixture was concentrated in vacuo to about 1 mL
  4. additionit was added to a flask
  5. temperatureto warm up to room temperature
  6. stirringstirred overnight for 16 h
  7. customAfter this time, the reaction mixture was quenched with an aqueous saturated sodium bicarbonate solution (10 mL)
  8. extractionextracted with methylene chloride (3×10 mL)
  9. washwashed with a 1N aqueous hydrochloric acid solution (10 mL)
  10. dry with materialdried over magnesium sulfate
  11. filtrationfiltered
  12. customto remove the drying agent
  13. concentrationthe filtrate concentrated in vacuo
  14. customThe crude material was purified

출처 및 근거

ORD 기록
ord-c2a4459b000b421fbc3731f5a8d1dfd6
출처 데이터셋
uspto-grants-2013_06
특허 번호
US08470866B2

연결된 노트

불러오는 중…